Pulmonary Embolism Severity Index and troponin testing for the selection of low-risk patients with acute symptomatic pulmonary embolism

L. Moores, D. Aujesky, D. Jiménez, G. Díaz, V. GóMez, D. Martí, S. Briongos, R. Yusen

Research output: Contribution to journalArticlepeer-review

65 Scopus citations

Abstract

Background: The combination of the Pulmonary Embolism Severity Index (PESI) and troponin testing could help physicians identify appropriate patients with acute pulmonary embolism (PE) for early hospital discharge. Methods: This prospective cohort study included a total of 567 patients from a single center registry with objectively confirmed acute symptomatic PE. On the basis of the PESI, each patient was classified into one of five classes (I-V). At the time of hospital admission, patients had troponin I (cTnI) levels measured. The endpoint of the study was all-cause mortality within 30 days after diagnosis. We calculated the mortality rates in four patient groups: group 1, PESI class I-II plus cTnI < 0.1 ng mL-1; group 2, PESI classes III-V plus cTnI < 0.1 ng mL-1; group 3, PESI classes I-II plus cTnI ≥ 0.1 ng mL-1; and group 4, PESI classes III-V plus cTnI ≥ 0.1 ng mL-1. Results: The study cohort had a 30-day mortality of 10% [95% confidence interval (CI), 7.6-12.5%]. Mortality rates in the four groups were 1.3%, 14.2%, 0% and 15.4%, respectively. Compared with non-elevated cTnl, the low-risk PESI had a higher negative predictive value (NPV) (98.9% vs. 90.8%) and negative likelihood ratio (NLR) (0.1 vs. 0.9) for predicting mortality. The addition of non-elevated cTnI to low-risk PESI did not improve the NPV or the NLR compared with either test alone. Conclusions: Compared with cTnl testing, PESI classification more accurately identified patients with PE who are at low risk of all-cause death within 30 days of presentation.

Original languageEnglish
Pages (from-to)517-522
Number of pages6
JournalJournal of Thrombosis and Haemostasis
Volume8
Issue number3
DOIs
StatePublished - Mar 2010

Keywords

  • Mortality
  • Prognosis
  • Pulmonary embolism
  • Thrombosis

Fingerprint

Dive into the research topics of 'Pulmonary Embolism Severity Index and troponin testing for the selection of low-risk patients with acute symptomatic pulmonary embolism'. Together they form a unique fingerprint.

Cite this